We are live on ! Find out more
DDD

SCOLR PHARMA, INC.
DDD

Delisted

DDD was delisted on the 12th of January, 2011.

Back to rankings

1 hedge funds and large institutions have $0 invested in SCOLR PHARMA, INC. in 2018 Q4 according to their latest regulatory filings, with funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding

Funds holding: 1 → 1 (0)

100% less capital invested

Capital invested by funds: $1K → $0 (-$1K)

Holders
1
Holders Change
–
Holders Change %
0%
% of All Funds
0.02%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter

DDD Hedge Fund Activity: Q4 2018 in Review

1 of the 4,505 institutional investors tracked by Wall St. Rank reported a position in SCOLR PHARMA, INC. (DDD) for Q4 2018, worth a combined $0 — down 100% from $1K a quarter earlier.

Fund positioning in DDD was balanced in Q4 2018: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 0 trimmed.

  • 1 institutional investor held SCOLR PHARMA, INC. (DDD) as of Q4 2018, unchanged from Q3 2018.
  • Funds reported $0 of SCOLR PHARMA, INC. stock for Q4 2018, down 100% quarter-over-quarter.
  • 0 funds opened new SCOLR PHARMA, INC. positions in Q4 2018 and 0 closed out.

Based on aggregated 13F filings for Q4 2018.